The global medical nonwoven market is expected to experience significant growth, reaching a market size of approximately US$ 2.1 billion by 2030. This growth is driven by factors such as increasing healthcare expenditures and a rising demand for infection control products.
The market is segmented into various application types, including:
The drapes and gowns segment is expected to dominate the market share due to its crucial role in infection control. The incontinence products segment is anticipated to be the fastest-growing area, driven by the aging population.
The Asia-Pacific region is projected to be the fastest-growing market for medical nonwovens. This growth is fueled by a large and expanding population, significant investments in healthcare infrastructure, and rapid economic development.
The overall expansion of the healthcare industry, increasing healthcare expenditure, and heightened awareness of hygiene are key drivers for the market.
The medical nonwoven market is segmented based on process type and material type. The spunlaid process and polypropylene material are expected to dominate.
The market is highly fragmented, with over 100 players competing, including Ahlstrom Oyj, Berry Global Group, Cardinal Health, and Kimberly-Clark Corporation. Companies are likely to focus on innovation and the development of new products to meet the changing needs of healthcare providers and patients. Sustainability and eco-friendly materials are also expected to shape the strategies of key players in the medical nonwoven sector.
Overall, the medical nonwoven market is poised for growth, driven by demographic shifts, healthcare investments, and evolving consumer preferences.